Physician profile
Michael Reilly
NPI 1104095827
$766.64
in general payments reported to CMS, 2019-2025
8 companies · $425 in 2025
The $425 reported for 2025 was more than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $26.66 · 2021: $17.29 · 2023: $148 · 2024: $40.28 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $613.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $233.26 | 2024-2025 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
| Acclarent, INC | $159.50 | 2019-2023 | Trudi Nav Cable |
| Abbvie INC. | $146.36 | 2023-2025 | |
| Stryker Corporation | $75.61 | 2025 | Na, Smartlock, Core |
| Depuy Synthes Sales INC. | $56.88 | 2025 | Matrixmandible, Trumatch, Matrixmidface |
| Regeneron Healthcare Solutions, INC. | $54.93 | 2025 | Dupixent |
| Aerin Medical INC. | $22.81 | 2024 | |
| Optinose US, INC. | $17.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Reilly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.